Parallel Advisors, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$75,520
+2.4%
623
-3.3%
0.00%
+50.0%
Q2 2023$73,751
+222.3%
644
+288.0%
0.00%
+100.0%
Q1 2023$22,880
+9.7%
166
+3.1%
0.00%0.0%
Q4 2022$20,862
-57.4%
161
-63.5%
0.00%
-50.0%
Q3 2022$49,000
+81.5%
441
+23.5%
0.00%
+100.0%
Q2 2022$27,000
-6.9%
357
-4.8%
0.00%0.0%
Q1 2022$29,000
-32.6%
375
-22.0%
0.00%
-50.0%
Q4 2021$43,000
+22.9%
481
+26.2%
0.00%
+100.0%
Q3 2021$35,000
+105.9%
381
+74.0%
0.00%0.0%
Q2 2021$17,000
+30.8%
219
+21.7%
0.00%0.0%
Q1 2021$13,000
+8.3%
180
+150.0%
0.00%0.0%
Q4 2020$12,000
+9.1%
72
-10.0%
0.00%0.0%
Q3 2020$11,000
-8.3%
800.0%0.00%0.0%
Q2 2020$12,000
+50.0%
80
-2.4%
0.00%0.0%
Q1 2020$8,000
+14.3%
82
+57.7%
0.00%0.0%
Q4 2019$7,000
+133.3%
52
+36.8%
0.00%
Q3 2019$3,000
-75.0%
38
-53.1%
0.00%
-100.0%
Q2 2019$12,000
+9.1%
81
-9.0%
0.00%0.0%
Q1 2019$11,000
+120.0%
89
+74.5%
0.00%0.0%
Q4 2018$5,000
-16.7%
51
+30.8%
0.00%0.0%
Q3 2018$6,000
+100.0%
39
+34.5%
0.00%
Q2 2018$3,000
+50.0%
290.0%0.00%
Q1 2018$2,0000.0%290.0%0.00%
Q4 2017$2,0000.0%290.0%0.00%
Q3 2017$2,000
-84.6%
29
-91.2%
0.00%
-100.0%
Q2 2017$13,000
+550.0%
329
+467.2%
0.00%
Q1 2017$2,000580.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders